Background: Members of the Bacillus genus produce a large variety of antimicrobial peptides including linear or cyclic lipopeptides and thiopeptides, that often have a broad spectrum of action against Gram-positive and Gram-negative bacteria. We have recently reported that SF214, a marine isolated strain of Bacillus pumilus, produces two different antimicrobials specifically active against either Staphylococcus aureus or Listeria monocytogenes. The anti-Staphylococcus molecule has been previously characterized as a pumilacidin, a nonribosomally synthesized lipopetide composed of a mixture of cyclic heptapeptides linked to fatty acids of variable length. Results: Our analysis on the anti-Listeria molecule of B. pumilus SF214 indicated that it is a peptide slightly smaller than 10 kDa, produced during the exponential phase of growth, stable at a wide range of pH conditions and resistant to various chemical treatments. The peptide showed a lytic activity against growing but not resting cells of Listeria monocytogenes and appeared extremely specific being inactive also against L. innocua, a close relative of L. monocytogenes. Conclusions: These findings indicate that the B. pumilus peptide is unusual with respect to other antimicrobials both for its time of synthesis and secretion and for its strict specificity against L. monocytogenes. Such specificity, together with its stability, propose this new antimicrobial as a tool for potential biotechnological applications in the fight against the dangerous food-borne pathogen L. monocytogenes.
In dioecious plants, the process of sex determination usually occurs during the reproductive stage. However, it can be challenging to determine the sex of long-lived plants with long generation times. This is true for Cycas revoluta, which produces toxic seeds in female plants, leading to a preference for male plants in public green spaces. In this study we aim to identify a morphological trait that can be used to distinguish between the sexes in C. revoluta at a very early stage of plant growth. We sampled C. revoluta seedlings/plantlets at three different early growth stages and identified the sex of individuals by PCR amplification of a male-specific molecular marker. On the same plants, we measured morphological traits, including the distance between leaflets on the leaf rachis, perimeter, area, number of indents, and leaf complexity, and evaluated their correlation with the sex of the individuals. Among all measured traits, the medium distance between leaflets on the leaf rachis was found to be a sexually dimorphic morphological trait in Cycas plantlets in all three growth stages. In particular, the distance between leaflets on the leaf rachis in the upper part of the leaf in the first stage revealed no overlap between the sexes. Whenever available, morphological traits for sex differentiation in greenhouses and plant nurseries can represent a rapid and economic tool when coupled with automatized image recognition systems.
The search for next-generation probiotics derived from the human gut microbiota has intensified due to their potential beneficial effects in modulating immunity and preventing diseases. Spore-forming bacteria are attractive probiotic candidates due to their functional traits and unique resilience, which offer high stability to commercial formulations. In this study, spore-forming bacteria isolated from human fecal samples were screened. Two strains, Bacillus spizizenii A1 and Priestia megaterium F6, were identified as non-hemolytic and not resistant to a panel of antibiotics relevant for spore formers. Both strains were characterized by using in silico and in vitro approaches, demonstrating relevant probiotic potential. The comparative analysis indicated B. spizizenii A1 as the most promising probiotic candidate due to the resistance of its spores to simulated gastric conditions and for its antioxidant, antimicrobial, and antibiofilm activities. Strain A1 combines a safety profile with functional probiotic traits and is therefore a strong candidate for further in vivo evaluation and future development as a next-generation probiotic.